New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China

AIDS Research and Human Retroviruses

Volumn 27, Issue 10, 2011, Pages 1047-1053

  Zhao, Bin ^a   Han, Xiaoxu ^a   Dai, Di ^a   Liu, Jing ^a   Ding, Haibo ^a   Xu, Junjie ^a   Chu, Zhenxing ^a   Bice, Tristan ^a   Diao, Yingying ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; AGED; ARTICLE; CHINA; COHORT ANALYSIS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUAL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CHINA; DRUG RESISTANCE, MULTIPLE, VIRAL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 79960435188     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0119     Document Type: Article

References (27)

1. The Ministry of Health of the People's Republic of China, Joint United Nations Programme on HIV/AIDS and World Health Organization. 2005 update on the HIV/AIDS epidemic and response in China [in Chinese]. Available at:www.chinaids.org.cn. Accessed January 2006.
2. Koblin BA, Chensney MA, Husnik MJ, et al.: High-risk behavior among men who have sex with men in 6 US cities: Baseline data from the EXPLORE study. Am J Public Health 2003;93:926-932. (Pubitemid 38480224)
3. Liu H, et al.: Men who have sex with men and human immunodeficiency virus: Sexually transmitted disease control in China. Sex Trans Dis 2006;33(2):68-76.
4. Wang L, Wang N, Wang L, et al.: The 2007 estimates for people at risk for and living with HIV in China: Progress and challenges. J Acquir Immune Defic Syndr 2009;50(4): 414-418.
5. AIDS epidemic update: November 2009. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2009.
6. Choi KH, Liu H, Guo YQ, et al.: Emerging HIV-1 in China in men who have sex with men.The Lancet 2003;361:2125-2126. (Pubitemid 36782259)
7. Qian ZH, Vermund SH, and Wang N: Risk of HIV/AIDS in China: Subpopulations of special importance. Sex Transm Infect 2005;81:442-447. (Pubitemid 41811321)
8. Shleman SH, et al.: Analysis of antiretroviral drug resistance and HIV-1 subtype among men who have sex with men recently infected with HIV-1 in the United States: The EXPLORE study. 15th International HIV Drug Resistance Workshop, Sitges, Spain, June 2006. Antiviral Ther 2006;11:S1222.
9. Zhang X, Li S, Li X, et al.: Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. AIDS 2007;21;59-65.
10. Han XX, Dai D, Lu C, et al.: Analysis on primary drug resistance of HIV-1 infected man having sex with man. China. J Public Health 2007;23(12):1415-1416.
11. Wang Z, Liang Y, and Xin T: Investigation on curative effect and drug resistance of HIV/AIDS patients receiving HAART. J Med Forum 2005;26:1-3.
12. Si XF, Huang HL, Wei M, Guan Q, Song YH, Ma P, et al.: Prevalence of drug resistance mutations among anti-retroviral drug-naive HIV-1-infected patients in China. Chin J Exp Clin Virol 2004;4:308-311.
13. Han XX, Zhang M, Dai T, Lu CM, Zhang ZN, Liu J, et al.: Background study of HIV-1 drug resistant mutations in treatment-naive patients in Liaoning province. Acta Acad Med Sin 2006;5:632-635.
14. Han X, Zhang M, Dai D, et al.: Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: Baseline prevalence and subtype-specific difference. AIDS Res Hum Ret-roviruses 2007;23(3):357-364. (Pubitemid 46608555)
15. Wensing A, Vercauteren J, Vijver DA, et al.: Transmission of drug-resistance in Europe is characterized by single mutations and revertants. Antiviral Ther 2006;11:S111.
16. Ross LL, Florance A, Wine B, et al.: Prevalence of HIV-1 drug resistance-associated mutations in a large cohort of anti-retroviral therapy (ART) naive HIV-infected individuals in the United States from 2000 to 2004. Antiviral Ther 2006;11(S):120.
17. Turner D and Wainberg MA. HIV transmission and primary drug resistance. AIDS Rev 2006;8(1):17-23.
18. Shao Y: Report on the 2nd National HIV Molecular Epidemiology Survey. Basic science update by the Chinese Ministry of Science and Technology [in Chinese]. 2004. Available at http://shgy.jhgl.org. Accessed November 2007.
19. Yao J, Zhang FJ, He ZP, Zhao HX, Li XW, Feng X, et al.: Subtype and sequence analysis of the C2-V3 region of the env gene among HIV-1 infected homosexual men in Beijing. Chin J STD/AIDS Prev Cont 2002;8:131-133.
20. Yao YP, Xin RL, He X, et al.: Molecular characteristics of HIV-1 CRF01 AE strains in Zhejiang province. Zhonghua Liu Xing Bing Xue Za Zhi 2008;29(2):161-165.
21. Chen JH, Wong KH, Li P, et al.: Molecular epidemiological study of HIV-1 CRF01AE transmission in Hong Kong. J Acquir Immune Defic Syndr 2009;51(5):530-535.
22. Lee CC, Sun YJ, Barkham T, et al.: Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore. HIV Med 2009;10(6):370-377.
23. Holguin A, Ramirez de Arellano E, et al.: Efficacy of anti-retroviral therapy in individuals infected with HIV-1 non-B subtypes. AIDS Rev 2006;8:98-107. (Pubitemid 44043558)
24. Liu J, Yue J, Wu S, and Yan Y: Polymorphisms and drug resistance analysis of HIV-1 CRF01AE strains circulating in Fujian Province, China. Arch Virol 2007;152(10):1799-1805.
25. Kearneya M, Palmera S, Maldarellia F, et al.: Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. AIDS 2008;22:497-501.
26. Mihailidis C, Dunn D, Pillay D, and Pozniak A: Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy. AIDS 2008;30;22(3):427-430.
27. Gatanaga H, Hachiya A, Kimura S, and Oka S: Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure. Virology 2006;344(2):354-362 (Pubitemid 43049623)